Base case results—intravenous infusions
| Condition | Cost per treatment episode | |||||||||||
| SSTI | Complex UTI | Orthopaedic-bone and joint | Diabetic foot | Bronchiectasis | Intra-abdominal | |||||||
| Model of care | ||||||||||||
| Inpatient stay | £2476 | – | £2104 | – | £8279 | – | £8428 | – | £3269 | – | £7124 | – |
| OPAT—once daily visits | £631 | 25% | £758 | 36% | £2506 | 30% | £2671 | 32% | – | – | £2312 | 32% |
| OPAT—specialist nurse daily home visit | £831 | 34% | £977 | 46% | £3375 | 41% | £3556 | 42% | £1839 | 56% | £3006 | 42% |
| OPAT—self-administration—intravenous bolus | £566 | 23% | £720 | 34% | £1855 | 22% | £2006 | 24% | £1301 | 40% | £1811 | 25% |
| OPAT—self-administration—elastomeric device | £611 | 25% | – | – | £2394 | 29% | £2433 | 29% | £1588 | 49% | £2952 | 41% |
| OPAT—elastomeric device (CIVI; outpatient) | £802 | 32% | – | – | – | – | – | – | £1495 | 46% | £2807 | 39% |
| OPAT—once-off dalbavancin (1 g) | £1266 | 51% | – | – | – | – | – | – | – | – | – | – |
CIVI, continuous intravenous infusion; OPAT, outpatient parenteral antimicrobial therapy; SSTI, skin and soft-tissue infections; UTI, urinary tract infections.